Experienced in Primary Immunodeficiency (PID)

Dr. Sitaramesh R. Emani

Advanced Heart Failure and Transplant Cardiology | Interventional Cardiology | Allergy and Immunology
The Christ Hospital Cardiovascular Associates LLC
2123 Auburn Ave, Suite 136, 
Cincinnati, OH 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Experienced in Primary Immunodeficiency (PID)
The Christ Hospital Cardiovascular Associates LLC
2123 Auburn Ave, Suite 136, 
Cincinnati, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Sitaramesh Emani is an Advanced Heart Failure and Transplant Cardiologist and an Interventional Cardiologist in Cincinnati, Ohio. Dr. Emani is rated as an Experienced provider by MediFind in the treatment of Primary Immunodeficiency (PID). His top areas of expertise are Cardiogenic Shock, Pulmonary Edema, Arrhythmogenic Right Ventricular Cardiomyopathy, Heart Transplant, and Percutaneous Coronary Intervention (PCI). Dr. Emani is currently accepting new patients.

His clinical research consists of co-authoring 32 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Advanced Heart Failure and Transplant Cardiology
Interventional Cardiology
Allergy and Immunology
Licenses
Internal Medicine in OH
Hospital Affiliations
Christ Hospital
Miami Valley Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medical Health
  • HMO
  • PPO
Medical Mutual
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

THE CHRIST HOSPITAL CARDIOVASCULAR ASSOCIATES LLC
2123 Auburn Ave, Suite 136, Cincinnati, OH 45219

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Tricuspid Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System and Optimal Medical Therapy (OMT) Compared to OMT Alone in Patients With Tricuspid Regurgitation
A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Tricuspid Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System and Optimal Medical Therapy (OMT) Compared to OMT Alone in Patients With Tricuspid Regurgitation
Enrollment Status: Recruiting
Publish Date: September 22, 2025
Intervention Type: Device, Drug
Study Phase: Not Applicable
Utility of Donor-Derived Cell-free DNA in Association With Gene-Expression Profiling (AlloMap®) in Heart Transplant Recipients (D-OAR)
Utility of Donor-Derived Cell-free DNA in Association With Gene-Expression Profiling (AlloMap®) in Heart Transplant Recipients (D-OAR)
Enrollment Status: Completed
Publish Date: October 29, 2024
A Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency /and Sub-Study
A Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency /and Sub-Study
Enrollment Status: Completed
Publish Date: July 03, 2024
Intervention Type: Drug
Study Drug: Ferric Carboxymaltose
Study Phase: Phase 3
Investigation to Optimize Hemodynamic Management of HeartMate II™ Left Ventricular Assist Device Patients Using the CardioMEMS™ Pulmonary Artery Pressure Sensor in Advanced Heart Failure
Investigation to Optimize Hemodynamic Management of HeartMate II™ Left Ventricular Assist Device Patients Using the CardioMEMS™ Pulmonary Artery Pressure Sensor in Advanced Heart Failure
Enrollment Status: Completed
Publish Date: April 26, 2024
Intervention Type: Device
The STOP-ADHF Study: Stimulation of the Cardiopulmonary Nervous System in Acute Decompensated Heart Failure
The STOP-ADHF Study: Stimulation of the Cardiopulmonary Nervous System in Acute Decompensated Heart Failure
Enrollment Status: Completed
Publish Date: February 28, 2024
Intervention Type: Other, Device
Study Phase: Not Applicable
Relationship Between LINQ™ Subcutaneous Impedance and Right-sided Hemodynamic Measurements
Relationship Between LINQ™ Subcutaneous Impedance and Right-sided Hemodynamic Measurements
Enrollment Status: Completed
Publish Date: December 23, 2022
Intervention Type: Device
Study Phase: Not Applicable
Dietary Supplementation in Heart Failure
Dietary Supplementation in Heart Failure
Enrollment Status: Completed
Publish Date: October 22, 2021
Intervention Type: Dietary supplement
Study Phase: Not Applicable
Evaluation of the EasySense System in Congestive Heart Failure
Evaluation of the EasySense System in Congestive Heart Failure
Enrollment Status: Completed
Publish Date: February 05, 2021
Intervention Type: Device
Outcomes AlloMap Registry Study: the Clinical Long-term Management and Outcomes of Heart Transplant Recipients With Regular Rejection Surveillance Including Use of AlloMap Gene-expression Profiling Testing
Outcomes AlloMap Registry Study: the Clinical Long-term Management and Outcomes of Heart Transplant Recipients With Regular Rejection Surveillance Including Use of AlloMap Gene-expression Profiling Testing
Enrollment Status: Unknown
Publish Date: February 05, 2020
Evaluation of Rate Adaptive Pacing on Chronotropic Response in Preserved Ejection Fraction HF
Evaluation of Rate Adaptive Pacing on Chronotropic Response in Preserved Ejection Fraction HF
Enrollment Status: Withdrawn
Publish Date: April 19, 2018
Intervention Type: Device
Study Phase: Not Applicable
View 9 Less Clinical Trials

31 Total Publications

Heart Rate Reduction Is Associated With Reverse Left Ventricular Remodeling and Mechanism-Specific Molecular Phenotypes in Dilated Cardiomyopathy.
Heart Rate Reduction Is Associated With Reverse Left Ventricular Remodeling and Mechanism-Specific Molecular Phenotypes in Dilated Cardiomyopathy.
Journal: Circulation. Heart failure
Published: March 07, 2025
Similar Doctors
Advanced in Primary Immunodeficiency (PID)
Dr. Arturo J. Bonnin
Allergy and Immunology
Advanced in Primary Immunodeficiency (PID)
Dr. Arturo J. Bonnin
Allergy and Immunology
8039 Washington Village Drive, Suite #100, 
Centerville, OH 
 (38.9 miles away)
937-435-8999
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Arturo Bonnin is an Allergy and Immunologist in Centerville, Ohio. Dr. Bonnin is rated as a Distinguished provider by MediFind in the treatment of Primary Immunodeficiency (PID). His top areas of expertise are Allergic Rhinitis, Sinusitis, Grass Allergy, and Chronic Spontaneous Urticaria (CSU). Dr. Bonnin is currently accepting new patients.

Advanced in Primary Immunodeficiency (PID)
Dr. Aliya U. Khan
Rheumatology | Allergy and Immunology
Advanced in Primary Immunodeficiency (PID)
Dr. Aliya U. Khan
Rheumatology | Allergy and Immunology

Dayton Arthritis And Allergy Center LLC

3075 Governors Place Blvd, Suite 110, 
Dayton, OH 
 (43.7 miles away)
937-296-0015
Languages Spoken:
English, Urdu
See accepted insurances
Accepting New Patients

Aliya Khan is a Rheumatologist and an Allergy and Immunologist in Dayton, Ohio. Dr. Khan is rated as an Advanced provider by MediFind in the treatment of Primary Immunodeficiency (PID). Her top areas of expertise are Sjogren Syndrome, Raynaud Phenomenon, Undifferentiated Connective Tissue Disease (UCTD), and Common Variable Immune Deficiency. Dr. Khan is currently accepting new patients.

Advanced in Primary Immunodeficiency (PID)
Dr. Jonathan A. Bernstein
Allergy and Immunology
Advanced in Primary Immunodeficiency (PID)
Dr. Jonathan A. Bernstein
Allergy and Immunology
4665 E Galbraith Rd Fl 2, 
Cincinnati, OH 
 (8.6 miles away)
513-931-0775
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jonathan Bernstein is an Allergy and Immunologist in Cincinnati, Ohio. Dr. Bernstein is rated as a Distinguished provider by MediFind in the treatment of Primary Immunodeficiency (PID). His top areas of expertise are Hereditary Alpha-Tryptasemia, Vibratory Urticaria, Chronic Spontaneous Urticaria (CSU), and Complement Component 2 Deficiency. Dr. Bernstein is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Emani's expertise for a condition
ConditionClose
    View All 37 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile